Global PD-1 Antibody Drug Supply, Demand and Key Producers, 2023-2029
The global PD-1 Antibody Drug market size is expected to reach $ 83340 million by 2029, rising at a market growth of 13.7% CAGR during the forecast period (2023-2029).
PD-1 is an immune checkpoint inhibitor, which is relatively widely used clinically
This report studies the global PD-1 Antibody Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for PD-1 Antibody Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of PD-1 Antibody Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global PD-1 Antibody Drug total production and demand, 2018-2029, (K Units)
Global PD-1 Antibody Drug total production value, 2018-2029, (USD Million)
Global PD-1 Antibody Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global PD-1 Antibody Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: PD-1 Antibody Drug domestic production, consumption, key domestic manufacturers and share
Global PD-1 Antibody Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global PD-1 Antibody Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global PD-1 Antibody Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global PD-1 Antibody Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Thermo Fisher, InvivoGen, BioVision Inc., Abcam, Bristol-Myers Squibb, Merck, Ono Pharmaceutical Co., Ltd and Eli Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PD-1 Antibody Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global PD-1 Antibody Drug Market, By Region:
1. How big is the global PD-1 Antibody Drug market?
2. What is the demand of the global PD-1 Antibody Drug market?
3. What is the year over year growth of the global PD-1 Antibody Drug market?
4. What is the production and production value of the global PD-1 Antibody Drug market?
5. Who are the key producers in the global PD-1 Antibody Drug market?
6. What are the growth factors driving the market demand?
PD-1 is an immune checkpoint inhibitor, which is relatively widely used clinically
This report studies the global PD-1 Antibody Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for PD-1 Antibody Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of PD-1 Antibody Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global PD-1 Antibody Drug total production and demand, 2018-2029, (K Units)
Global PD-1 Antibody Drug total production value, 2018-2029, (USD Million)
Global PD-1 Antibody Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global PD-1 Antibody Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: PD-1 Antibody Drug domestic production, consumption, key domestic manufacturers and share
Global PD-1 Antibody Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global PD-1 Antibody Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global PD-1 Antibody Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global PD-1 Antibody Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Thermo Fisher, InvivoGen, BioVision Inc., Abcam, Bristol-Myers Squibb, Merck, Ono Pharmaceutical Co., Ltd and Eli Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PD-1 Antibody Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global PD-1 Antibody Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Pembrolizumab
- Nivolumab
- Sindilimab
- Toripalimab
- Other
- Hospital
- Clinic
- Other
- Novartis
- Thermo Fisher
- InvivoGen
- BioVision Inc.
- Abcam
- Bristol-Myers Squibb
- Merck
- Ono Pharmaceutical Co., Ltd
- Eli Lilly
- Chugai Pharmaceutical Co., Ltd
- BeiGene
- AbbVie
- TG Therapeutics, Inc
- Beijing Yiqiao Shenzhou Technology Co., Ltd.
- 3SBio
1. How big is the global PD-1 Antibody Drug market?
2. What is the demand of the global PD-1 Antibody Drug market?
3. What is the year over year growth of the global PD-1 Antibody Drug market?
4. What is the production and production value of the global PD-1 Antibody Drug market?
5. Who are the key producers in the global PD-1 Antibody Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 PD-1 Antibody Drug Introduction
1.2 World PD-1 Antibody Drug Supply & Forecast
1.2.1 World PD-1 Antibody Drug Production Value (2018 & 2022 & 2029)
1.2.2 World PD-1 Antibody Drug Production (2018-2029)
1.2.3 World PD-1 Antibody Drug Pricing Trends (2018-2029)
1.3 World PD-1 Antibody Drug Production by Region (Based on Production Site)
1.3.1 World PD-1 Antibody Drug Production Value by Region (2018-2029)
1.3.2 World PD-1 Antibody Drug Production by Region (2018-2029)
1.3.3 World PD-1 Antibody Drug Average Price by Region (2018-2029)
1.3.4 North America PD-1 Antibody Drug Production (2018-2029)
1.3.5 Europe PD-1 Antibody Drug Production (2018-2029)
1.3.6 China PD-1 Antibody Drug Production (2018-2029)
1.3.7 Japan PD-1 Antibody Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 PD-1 Antibody Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PD-1 Antibody Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World PD-1 Antibody Drug Demand (2018-2029)
2.2 World PD-1 Antibody Drug Consumption by Region
2.2.1 World PD-1 Antibody Drug Consumption by Region (2018-2023)
2.2.2 World PD-1 Antibody Drug Consumption Forecast by Region (2024-2029)
2.3 United States PD-1 Antibody Drug Consumption (2018-2029)
2.4 China PD-1 Antibody Drug Consumption (2018-2029)
2.5 Europe PD-1 Antibody Drug Consumption (2018-2029)
2.6 Japan PD-1 Antibody Drug Consumption (2018-2029)
2.7 South Korea PD-1 Antibody Drug Consumption (2018-2029)
2.8 ASEAN PD-1 Antibody Drug Consumption (2018-2029)
2.9 India PD-1 Antibody Drug Consumption (2018-2029)
3 WORLD PD-1 ANTIBODY DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World PD-1 Antibody Drug Production Value by Manufacturer (2018-2023)
3.2 World PD-1 Antibody Drug Production by Manufacturer (2018-2023)
3.3 World PD-1 Antibody Drug Average Price by Manufacturer (2018-2023)
3.4 PD-1 Antibody Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PD-1 Antibody Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PD-1 Antibody Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for PD-1 Antibody Drug in 2022
3.6 PD-1 Antibody Drug Market: Overall Company Footprint Analysis
3.6.1 PD-1 Antibody Drug Market: Region Footprint
3.6.2 PD-1 Antibody Drug Market: Company Product Type Footprint
3.6.3 PD-1 Antibody Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: PD-1 Antibody Drug Production Value Comparison
4.1.1 United States VS China: PD-1 Antibody Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: PD-1 Antibody Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: PD-1 Antibody Drug Production Comparison
4.2.1 United States VS China: PD-1 Antibody Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: PD-1 Antibody Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: PD-1 Antibody Drug Consumption Comparison
4.3.1 United States VS China: PD-1 Antibody Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: PD-1 Antibody Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based PD-1 Antibody Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based PD-1 Antibody Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers PD-1 Antibody Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers PD-1 Antibody Drug Production (2018-2023)
4.5 China Based PD-1 Antibody Drug Manufacturers and Market Share
4.5.1 China Based PD-1 Antibody Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers PD-1 Antibody Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers PD-1 Antibody Drug Production (2018-2023)
4.6 Rest of World Based PD-1 Antibody Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based PD-1 Antibody Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers PD-1 Antibody Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers PD-1 Antibody Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World PD-1 Antibody Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Pembrolizumab
5.2.2 Nivolumab
5.2.3 Sindilimab
5.2.4 Toripalimab
5.2.5 Other
5.3 Market Segment by Type
5.3.1 World PD-1 Antibody Drug Production by Type (2018-2029)
5.3.2 World PD-1 Antibody Drug Production Value by Type (2018-2029)
5.3.3 World PD-1 Antibody Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World PD-1 Antibody Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World PD-1 Antibody Drug Production by Application (2018-2029)
6.3.2 World PD-1 Antibody Drug Production Value by Application (2018-2029)
6.3.3 World PD-1 Antibody Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis PD-1 Antibody Drug Product and Services
7.1.4 Novartis PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Thermo Fisher
7.2.1 Thermo Fisher Details
7.2.2 Thermo Fisher Major Business
7.2.3 Thermo Fisher PD-1 Antibody Drug Product and Services
7.2.4 Thermo Fisher PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Recent Developments/Updates
7.2.6 Thermo Fisher Competitive Strengths & Weaknesses
7.3 InvivoGen
7.3.1 InvivoGen Details
7.3.2 InvivoGen Major Business
7.3.3 InvivoGen PD-1 Antibody Drug Product and Services
7.3.4 InvivoGen PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 InvivoGen Recent Developments/Updates
7.3.6 InvivoGen Competitive Strengths & Weaknesses
7.4 BioVision Inc.
7.4.1 BioVision Inc. Details
7.4.2 BioVision Inc. Major Business
7.4.3 BioVision Inc. PD-1 Antibody Drug Product and Services
7.4.4 BioVision Inc. PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 BioVision Inc. Recent Developments/Updates
7.4.6 BioVision Inc. Competitive Strengths & Weaknesses
7.5 Abcam
7.5.1 Abcam Details
7.5.2 Abcam Major Business
7.5.3 Abcam PD-1 Antibody Drug Product and Services
7.5.4 Abcam PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Abcam Recent Developments/Updates
7.5.6 Abcam Competitive Strengths & Weaknesses
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Details
7.6.2 Bristol-Myers Squibb Major Business
7.6.3 Bristol-Myers Squibb PD-1 Antibody Drug Product and Services
7.6.4 Bristol-Myers Squibb PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bristol-Myers Squibb Recent Developments/Updates
7.6.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.7 Merck
7.7.1 Merck Details
7.7.2 Merck Major Business
7.7.3 Merck PD-1 Antibody Drug Product and Services
7.7.4 Merck PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Merck Recent Developments/Updates
7.7.6 Merck Competitive Strengths & Weaknesses
7.8 Ono Pharmaceutical Co., Ltd
7.8.1 Ono Pharmaceutical Co., Ltd Details
7.8.2 Ono Pharmaceutical Co., Ltd Major Business
7.8.3 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
7.8.4 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
7.8.6 Ono Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.9 Eli Lilly
7.9.1 Eli Lilly Details
7.9.2 Eli Lilly Major Business
7.9.3 Eli Lilly PD-1 Antibody Drug Product and Services
7.9.4 Eli Lilly PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Eli Lilly Recent Developments/Updates
7.9.6 Eli Lilly Competitive Strengths & Weaknesses
7.10 Chugai Pharmaceutical Co., Ltd
7.10.1 Chugai Pharmaceutical Co., Ltd Details
7.10.2 Chugai Pharmaceutical Co., Ltd Major Business
7.10.3 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
7.10.4 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Chugai Pharmaceutical Co., Ltd Recent Developments/Updates
7.10.6 Chugai Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.11 BeiGene
7.11.1 BeiGene Details
7.11.2 BeiGene Major Business
7.11.3 BeiGene PD-1 Antibody Drug Product and Services
7.11.4 BeiGene PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 BeiGene Recent Developments/Updates
7.11.6 BeiGene Competitive Strengths & Weaknesses
7.12 AbbVie
7.12.1 AbbVie Details
7.12.2 AbbVie Major Business
7.12.3 AbbVie PD-1 Antibody Drug Product and Services
7.12.4 AbbVie PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 AbbVie Recent Developments/Updates
7.12.6 AbbVie Competitive Strengths & Weaknesses
7.13 TG Therapeutics, Inc
7.13.1 TG Therapeutics, Inc Details
7.13.2 TG Therapeutics, Inc Major Business
7.13.3 TG Therapeutics, Inc PD-1 Antibody Drug Product and Services
7.13.4 TG Therapeutics, Inc PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 TG Therapeutics, Inc Recent Developments/Updates
7.13.6 TG Therapeutics, Inc Competitive Strengths & Weaknesses
7.14 Beijing Yiqiao Shenzhou Technology Co., Ltd.
7.14.1 Beijing Yiqiao Shenzhou Technology Co., Ltd. Details
7.14.2 Beijing Yiqiao Shenzhou Technology Co., Ltd. Major Business
7.14.3 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product and Services
7.14.4 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Beijing Yiqiao Shenzhou Technology Co., Ltd. Recent Developments/Updates
7.14.6 Beijing Yiqiao Shenzhou Technology Co., Ltd. Competitive Strengths & Weaknesses
7.15 3SBio
7.15.1 3SBio Details
7.15.2 3SBio Major Business
7.15.3 3SBio PD-1 Antibody Drug Product and Services
7.15.4 3SBio PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 3SBio Recent Developments/Updates
7.15.6 3SBio Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 PD-1 Antibody Drug Industry Chain
8.2 PD-1 Antibody Drug Upstream Analysis
8.2.1 PD-1 Antibody Drug Core Raw Materials
8.2.2 Main Manufacturers of PD-1 Antibody Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 PD-1 Antibody Drug Production Mode
8.6 PD-1 Antibody Drug Procurement Model
8.7 PD-1 Antibody Drug Industry Sales Model and Sales Channels
8.7.1 PD-1 Antibody Drug Sales Model
8.7.2 PD-1 Antibody Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 PD-1 Antibody Drug Introduction
1.2 World PD-1 Antibody Drug Supply & Forecast
1.2.1 World PD-1 Antibody Drug Production Value (2018 & 2022 & 2029)
1.2.2 World PD-1 Antibody Drug Production (2018-2029)
1.2.3 World PD-1 Antibody Drug Pricing Trends (2018-2029)
1.3 World PD-1 Antibody Drug Production by Region (Based on Production Site)
1.3.1 World PD-1 Antibody Drug Production Value by Region (2018-2029)
1.3.2 World PD-1 Antibody Drug Production by Region (2018-2029)
1.3.3 World PD-1 Antibody Drug Average Price by Region (2018-2029)
1.3.4 North America PD-1 Antibody Drug Production (2018-2029)
1.3.5 Europe PD-1 Antibody Drug Production (2018-2029)
1.3.6 China PD-1 Antibody Drug Production (2018-2029)
1.3.7 Japan PD-1 Antibody Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 PD-1 Antibody Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PD-1 Antibody Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World PD-1 Antibody Drug Demand (2018-2029)
2.2 World PD-1 Antibody Drug Consumption by Region
2.2.1 World PD-1 Antibody Drug Consumption by Region (2018-2023)
2.2.2 World PD-1 Antibody Drug Consumption Forecast by Region (2024-2029)
2.3 United States PD-1 Antibody Drug Consumption (2018-2029)
2.4 China PD-1 Antibody Drug Consumption (2018-2029)
2.5 Europe PD-1 Antibody Drug Consumption (2018-2029)
2.6 Japan PD-1 Antibody Drug Consumption (2018-2029)
2.7 South Korea PD-1 Antibody Drug Consumption (2018-2029)
2.8 ASEAN PD-1 Antibody Drug Consumption (2018-2029)
2.9 India PD-1 Antibody Drug Consumption (2018-2029)
3 WORLD PD-1 ANTIBODY DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World PD-1 Antibody Drug Production Value by Manufacturer (2018-2023)
3.2 World PD-1 Antibody Drug Production by Manufacturer (2018-2023)
3.3 World PD-1 Antibody Drug Average Price by Manufacturer (2018-2023)
3.4 PD-1 Antibody Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PD-1 Antibody Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PD-1 Antibody Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for PD-1 Antibody Drug in 2022
3.6 PD-1 Antibody Drug Market: Overall Company Footprint Analysis
3.6.1 PD-1 Antibody Drug Market: Region Footprint
3.6.2 PD-1 Antibody Drug Market: Company Product Type Footprint
3.6.3 PD-1 Antibody Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: PD-1 Antibody Drug Production Value Comparison
4.1.1 United States VS China: PD-1 Antibody Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: PD-1 Antibody Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: PD-1 Antibody Drug Production Comparison
4.2.1 United States VS China: PD-1 Antibody Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: PD-1 Antibody Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: PD-1 Antibody Drug Consumption Comparison
4.3.1 United States VS China: PD-1 Antibody Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: PD-1 Antibody Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based PD-1 Antibody Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based PD-1 Antibody Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers PD-1 Antibody Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers PD-1 Antibody Drug Production (2018-2023)
4.5 China Based PD-1 Antibody Drug Manufacturers and Market Share
4.5.1 China Based PD-1 Antibody Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers PD-1 Antibody Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers PD-1 Antibody Drug Production (2018-2023)
4.6 Rest of World Based PD-1 Antibody Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based PD-1 Antibody Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers PD-1 Antibody Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers PD-1 Antibody Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World PD-1 Antibody Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Pembrolizumab
5.2.2 Nivolumab
5.2.3 Sindilimab
5.2.4 Toripalimab
5.2.5 Other
5.3 Market Segment by Type
5.3.1 World PD-1 Antibody Drug Production by Type (2018-2029)
5.3.2 World PD-1 Antibody Drug Production Value by Type (2018-2029)
5.3.3 World PD-1 Antibody Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World PD-1 Antibody Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World PD-1 Antibody Drug Production by Application (2018-2029)
6.3.2 World PD-1 Antibody Drug Production Value by Application (2018-2029)
6.3.3 World PD-1 Antibody Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis PD-1 Antibody Drug Product and Services
7.1.4 Novartis PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Thermo Fisher
7.2.1 Thermo Fisher Details
7.2.2 Thermo Fisher Major Business
7.2.3 Thermo Fisher PD-1 Antibody Drug Product and Services
7.2.4 Thermo Fisher PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Recent Developments/Updates
7.2.6 Thermo Fisher Competitive Strengths & Weaknesses
7.3 InvivoGen
7.3.1 InvivoGen Details
7.3.2 InvivoGen Major Business
7.3.3 InvivoGen PD-1 Antibody Drug Product and Services
7.3.4 InvivoGen PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 InvivoGen Recent Developments/Updates
7.3.6 InvivoGen Competitive Strengths & Weaknesses
7.4 BioVision Inc.
7.4.1 BioVision Inc. Details
7.4.2 BioVision Inc. Major Business
7.4.3 BioVision Inc. PD-1 Antibody Drug Product and Services
7.4.4 BioVision Inc. PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 BioVision Inc. Recent Developments/Updates
7.4.6 BioVision Inc. Competitive Strengths & Weaknesses
7.5 Abcam
7.5.1 Abcam Details
7.5.2 Abcam Major Business
7.5.3 Abcam PD-1 Antibody Drug Product and Services
7.5.4 Abcam PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Abcam Recent Developments/Updates
7.5.6 Abcam Competitive Strengths & Weaknesses
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Details
7.6.2 Bristol-Myers Squibb Major Business
7.6.3 Bristol-Myers Squibb PD-1 Antibody Drug Product and Services
7.6.4 Bristol-Myers Squibb PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bristol-Myers Squibb Recent Developments/Updates
7.6.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.7 Merck
7.7.1 Merck Details
7.7.2 Merck Major Business
7.7.3 Merck PD-1 Antibody Drug Product and Services
7.7.4 Merck PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Merck Recent Developments/Updates
7.7.6 Merck Competitive Strengths & Weaknesses
7.8 Ono Pharmaceutical Co., Ltd
7.8.1 Ono Pharmaceutical Co., Ltd Details
7.8.2 Ono Pharmaceutical Co., Ltd Major Business
7.8.3 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
7.8.4 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
7.8.6 Ono Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.9 Eli Lilly
7.9.1 Eli Lilly Details
7.9.2 Eli Lilly Major Business
7.9.3 Eli Lilly PD-1 Antibody Drug Product and Services
7.9.4 Eli Lilly PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Eli Lilly Recent Developments/Updates
7.9.6 Eli Lilly Competitive Strengths & Weaknesses
7.10 Chugai Pharmaceutical Co., Ltd
7.10.1 Chugai Pharmaceutical Co., Ltd Details
7.10.2 Chugai Pharmaceutical Co., Ltd Major Business
7.10.3 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
7.10.4 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Chugai Pharmaceutical Co., Ltd Recent Developments/Updates
7.10.6 Chugai Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.11 BeiGene
7.11.1 BeiGene Details
7.11.2 BeiGene Major Business
7.11.3 BeiGene PD-1 Antibody Drug Product and Services
7.11.4 BeiGene PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 BeiGene Recent Developments/Updates
7.11.6 BeiGene Competitive Strengths & Weaknesses
7.12 AbbVie
7.12.1 AbbVie Details
7.12.2 AbbVie Major Business
7.12.3 AbbVie PD-1 Antibody Drug Product and Services
7.12.4 AbbVie PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 AbbVie Recent Developments/Updates
7.12.6 AbbVie Competitive Strengths & Weaknesses
7.13 TG Therapeutics, Inc
7.13.1 TG Therapeutics, Inc Details
7.13.2 TG Therapeutics, Inc Major Business
7.13.3 TG Therapeutics, Inc PD-1 Antibody Drug Product and Services
7.13.4 TG Therapeutics, Inc PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 TG Therapeutics, Inc Recent Developments/Updates
7.13.6 TG Therapeutics, Inc Competitive Strengths & Weaknesses
7.14 Beijing Yiqiao Shenzhou Technology Co., Ltd.
7.14.1 Beijing Yiqiao Shenzhou Technology Co., Ltd. Details
7.14.2 Beijing Yiqiao Shenzhou Technology Co., Ltd. Major Business
7.14.3 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product and Services
7.14.4 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Beijing Yiqiao Shenzhou Technology Co., Ltd. Recent Developments/Updates
7.14.6 Beijing Yiqiao Shenzhou Technology Co., Ltd. Competitive Strengths & Weaknesses
7.15 3SBio
7.15.1 3SBio Details
7.15.2 3SBio Major Business
7.15.3 3SBio PD-1 Antibody Drug Product and Services
7.15.4 3SBio PD-1 Antibody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 3SBio Recent Developments/Updates
7.15.6 3SBio Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 PD-1 Antibody Drug Industry Chain
8.2 PD-1 Antibody Drug Upstream Analysis
8.2.1 PD-1 Antibody Drug Core Raw Materials
8.2.2 Main Manufacturers of PD-1 Antibody Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 PD-1 Antibody Drug Production Mode
8.6 PD-1 Antibody Drug Procurement Model
8.7 PD-1 Antibody Drug Industry Sales Model and Sales Channels
8.7.1 PD-1 Antibody Drug Sales Model
8.7.2 PD-1 Antibody Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World PD-1 Antibody Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World PD-1 Antibody Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World PD-1 Antibody Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World PD-1 Antibody Drug Production Value Market Share by Region (2018-2023)
Table 5. World PD-1 Antibody Drug Production Value Market Share by Region (2024-2029)
Table 6. World PD-1 Antibody Drug Production by Region (2018-2023) & (K Units)
Table 7. World PD-1 Antibody Drug Production by Region (2024-2029) & (K Units)
Table 8. World PD-1 Antibody Drug Production Market Share by Region (2018-2023)
Table 9. World PD-1 Antibody Drug Production Market Share by Region (2024-2029)
Table 10. World PD-1 Antibody Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World PD-1 Antibody Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. PD-1 Antibody Drug Major Market Trends
Table 13. World PD-1 Antibody Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World PD-1 Antibody Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World PD-1 Antibody Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World PD-1 Antibody Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key PD-1 Antibody Drug Producers in 2022
Table 18. World PD-1 Antibody Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key PD-1 Antibody Drug Producers in 2022
Table 20. World PD-1 Antibody Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global PD-1 Antibody Drug Company Evaluation Quadrant
Table 22. World PD-1 Antibody Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and PD-1 Antibody Drug Production Site of Key Manufacturer
Table 24. PD-1 Antibody Drug Market: Company Product Type Footprint
Table 25. PD-1 Antibody Drug Market: Company Product Application Footprint
Table 26. PD-1 Antibody Drug Competitive Factors
Table 27. PD-1 Antibody Drug New Entrant and Capacity Expansion Plans
Table 28. PD-1 Antibody Drug Mergers & Acquisitions Activity
Table 29. United States VS China PD-1 Antibody Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China PD-1 Antibody Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China PD-1 Antibody Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based PD-1 Antibody Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers PD-1 Antibody Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers PD-1 Antibody Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers PD-1 Antibody Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers PD-1 Antibody Drug Production Market Share (2018-2023)
Table 37. China Based PD-1 Antibody Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers PD-1 Antibody Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers PD-1 Antibody Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers PD-1 Antibody Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers PD-1 Antibody Drug Production Market Share (2018-2023)
Table 42. Rest of World Based PD-1 Antibody Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers PD-1 Antibody Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers PD-1 Antibody Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers PD-1 Antibody Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers PD-1 Antibody Drug Production Market Share (2018-2023)
Table 47. World PD-1 Antibody Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World PD-1 Antibody Drug Production by Type (2018-2023) & (K Units)
Table 49. World PD-1 Antibody Drug Production by Type (2024-2029) & (K Units)
Table 50. World PD-1 Antibody Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World PD-1 Antibody Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World PD-1 Antibody Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World PD-1 Antibody Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World PD-1 Antibody Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World PD-1 Antibody Drug Production by Application (2018-2023) & (K Units)
Table 56. World PD-1 Antibody Drug Production by Application (2024-2029) & (K Units)
Table 57. World PD-1 Antibody Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World PD-1 Antibody Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World PD-1 Antibody Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World PD-1 Antibody Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis PD-1 Antibody Drug Product and Services
Table 64. Novartis PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 68. Thermo Fisher Major Business
Table 69. Thermo Fisher PD-1 Antibody Drug Product and Services
Table 70. Thermo Fisher PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Thermo Fisher Recent Developments/Updates
Table 72. Thermo Fisher Competitive Strengths & Weaknesses
Table 73. InvivoGen Basic Information, Manufacturing Base and Competitors
Table 74. InvivoGen Major Business
Table 75. InvivoGen PD-1 Antibody Drug Product and Services
Table 76. InvivoGen PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. InvivoGen Recent Developments/Updates
Table 78. InvivoGen Competitive Strengths & Weaknesses
Table 79. BioVision Inc. Basic Information, Manufacturing Base and Competitors
Table 80. BioVision Inc. Major Business
Table 81. BioVision Inc. PD-1 Antibody Drug Product and Services
Table 82. BioVision Inc. PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. BioVision Inc. Recent Developments/Updates
Table 84. BioVision Inc. Competitive Strengths & Weaknesses
Table 85. Abcam Basic Information, Manufacturing Base and Competitors
Table 86. Abcam Major Business
Table 87. Abcam PD-1 Antibody Drug Product and Services
Table 88. Abcam PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Abcam Recent Developments/Updates
Table 90. Abcam Competitive Strengths & Weaknesses
Table 91. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 92. Bristol-Myers Squibb Major Business
Table 93. Bristol-Myers Squibb PD-1 Antibody Drug Product and Services
Table 94. Bristol-Myers Squibb PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bristol-Myers Squibb Recent Developments/Updates
Table 96. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 97. Merck Basic Information, Manufacturing Base and Competitors
Table 98. Merck Major Business
Table 99. Merck PD-1 Antibody Drug Product and Services
Table 100. Merck PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Merck Recent Developments/Updates
Table 102. Merck Competitive Strengths & Weaknesses
Table 103. Ono Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Ono Pharmaceutical Co., Ltd Major Business
Table 105. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
Table 106. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Ono Pharmaceutical Co., Ltd Recent Developments/Updates
Table 108. Ono Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 109. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 110. Eli Lilly Major Business
Table 111. Eli Lilly PD-1 Antibody Drug Product and Services
Table 112. Eli Lilly PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Eli Lilly Recent Developments/Updates
Table 114. Eli Lilly Competitive Strengths & Weaknesses
Table 115. Chugai Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Chugai Pharmaceutical Co., Ltd Major Business
Table 117. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
Table 118. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Chugai Pharmaceutical Co., Ltd Recent Developments/Updates
Table 120. Chugai Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 121. BeiGene Basic Information, Manufacturing Base and Competitors
Table 122. BeiGene Major Business
Table 123. BeiGene PD-1 Antibody Drug Product and Services
Table 124. BeiGene PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. BeiGene Recent Developments/Updates
Table 126. BeiGene Competitive Strengths & Weaknesses
Table 127. AbbVie Basic Information, Manufacturing Base and Competitors
Table 128. AbbVie Major Business
Table 129. AbbVie PD-1 Antibody Drug Product and Services
Table 130. AbbVie PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. AbbVie Recent Developments/Updates
Table 132. AbbVie Competitive Strengths & Weaknesses
Table 133. TG Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 134. TG Therapeutics, Inc Major Business
Table 135. TG Therapeutics, Inc PD-1 Antibody Drug Product and Services
Table 136. TG Therapeutics, Inc PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. TG Therapeutics, Inc Recent Developments/Updates
Table 138. TG Therapeutics, Inc Competitive Strengths & Weaknesses
Table 139. Beijing Yiqiao Shenzhou Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 140. Beijing Yiqiao Shenzhou Technology Co., Ltd. Major Business
Table 141. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product and Services
Table 142. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Beijing Yiqiao Shenzhou Technology Co., Ltd. Recent Developments/Updates
Table 144. 3SBio Basic Information, Manufacturing Base and Competitors
Table 145. 3SBio Major Business
Table 146. 3SBio PD-1 Antibody Drug Product and Services
Table 147. 3SBio PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of PD-1 Antibody Drug Upstream (Raw Materials)
Table 149. PD-1 Antibody Drug Typical Customers
Table 150. PD-1 Antibody Drug Typical Distributors
List of Figure
Figure 1. PD-1 Antibody Drug Picture
Figure 2. World PD-1 Antibody Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World PD-1 Antibody Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World PD-1 Antibody Drug Production (2018-2029) & (K Units)
Figure 5. World PD-1 Antibody Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World PD-1 Antibody Drug Production Value Market Share by Region (2018-2029)
Figure 7. World PD-1 Antibody Drug Production Market Share by Region (2018-2029)
Figure 8. North America PD-1 Antibody Drug Production (2018-2029) & (K Units)
Figure 9. Europe PD-1 Antibody Drug Production (2018-2029) & (K Units)
Figure 10. China PD-1 Antibody Drug Production (2018-2029) & (K Units)
Figure 11. Japan PD-1 Antibody Drug Production (2018-2029) & (K Units)
Figure 12. PD-1 Antibody Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World PD-1 Antibody Drug Consumption (2018-2029) & (K Units)
Figure 15. World PD-1 Antibody Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States PD-1 Antibody Drug Consumption (2018-2029) & (K Units)
Figure 17. China PD-1 Antibody Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe PD-1 Antibody Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan PD-1 Antibody Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea PD-1 Antibody Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN PD-1 Antibody Drug Consumption (2018-2029) & (K Units)
Figure 22. India PD-1 Antibody Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of PD-1 Antibody Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for PD-1 Antibody Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for PD-1 Antibody Drug Markets in 2022
Figure 26. United States VS China: PD-1 Antibody Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: PD-1 Antibody Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: PD-1 Antibody Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers PD-1 Antibody Drug Production Market Share 2022
Figure 30. China Based Manufacturers PD-1 Antibody Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers PD-1 Antibody Drug Production Market Share 2022
Figure 32. World PD-1 Antibody Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World PD-1 Antibody Drug Production Value Market Share by Type in 2022
Figure 34. Pembrolizumab
Figure 35. Nivolumab
Figure 36. Sindilimab
Figure 37. Toripalimab
Figure 38. Other
Figure 39. World PD-1 Antibody Drug Production Market Share by Type (2018-2029)
Figure 40. World PD-1 Antibody Drug Production Value Market Share by Type (2018-2029)
Figure 41. World PD-1 Antibody Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 42. World PD-1 Antibody Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 43. World PD-1 Antibody Drug Production Value Market Share by Application in 2022
Figure 44. Hospital
Figure 45. Clinic
Figure 46. Other
Figure 47. World PD-1 Antibody Drug Production Market Share by Application (2018-2029)
Figure 48. World PD-1 Antibody Drug Production Value Market Share by Application (2018-2029)
Figure 49. World PD-1 Antibody Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. PD-1 Antibody Drug Industry Chain
Figure 51. PD-1 Antibody Drug Procurement Model
Figure 52. PD-1 Antibody Drug Sales Model
Figure 53. PD-1 Antibody Drug Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Table 1. World PD-1 Antibody Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World PD-1 Antibody Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World PD-1 Antibody Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World PD-1 Antibody Drug Production Value Market Share by Region (2018-2023)
Table 5. World PD-1 Antibody Drug Production Value Market Share by Region (2024-2029)
Table 6. World PD-1 Antibody Drug Production by Region (2018-2023) & (K Units)
Table 7. World PD-1 Antibody Drug Production by Region (2024-2029) & (K Units)
Table 8. World PD-1 Antibody Drug Production Market Share by Region (2018-2023)
Table 9. World PD-1 Antibody Drug Production Market Share by Region (2024-2029)
Table 10. World PD-1 Antibody Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World PD-1 Antibody Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. PD-1 Antibody Drug Major Market Trends
Table 13. World PD-1 Antibody Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World PD-1 Antibody Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World PD-1 Antibody Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World PD-1 Antibody Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key PD-1 Antibody Drug Producers in 2022
Table 18. World PD-1 Antibody Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key PD-1 Antibody Drug Producers in 2022
Table 20. World PD-1 Antibody Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global PD-1 Antibody Drug Company Evaluation Quadrant
Table 22. World PD-1 Antibody Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and PD-1 Antibody Drug Production Site of Key Manufacturer
Table 24. PD-1 Antibody Drug Market: Company Product Type Footprint
Table 25. PD-1 Antibody Drug Market: Company Product Application Footprint
Table 26. PD-1 Antibody Drug Competitive Factors
Table 27. PD-1 Antibody Drug New Entrant and Capacity Expansion Plans
Table 28. PD-1 Antibody Drug Mergers & Acquisitions Activity
Table 29. United States VS China PD-1 Antibody Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China PD-1 Antibody Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China PD-1 Antibody Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based PD-1 Antibody Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers PD-1 Antibody Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers PD-1 Antibody Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers PD-1 Antibody Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers PD-1 Antibody Drug Production Market Share (2018-2023)
Table 37. China Based PD-1 Antibody Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers PD-1 Antibody Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers PD-1 Antibody Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers PD-1 Antibody Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers PD-1 Antibody Drug Production Market Share (2018-2023)
Table 42. Rest of World Based PD-1 Antibody Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers PD-1 Antibody Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers PD-1 Antibody Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers PD-1 Antibody Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers PD-1 Antibody Drug Production Market Share (2018-2023)
Table 47. World PD-1 Antibody Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World PD-1 Antibody Drug Production by Type (2018-2023) & (K Units)
Table 49. World PD-1 Antibody Drug Production by Type (2024-2029) & (K Units)
Table 50. World PD-1 Antibody Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World PD-1 Antibody Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World PD-1 Antibody Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World PD-1 Antibody Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World PD-1 Antibody Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World PD-1 Antibody Drug Production by Application (2018-2023) & (K Units)
Table 56. World PD-1 Antibody Drug Production by Application (2024-2029) & (K Units)
Table 57. World PD-1 Antibody Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World PD-1 Antibody Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World PD-1 Antibody Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World PD-1 Antibody Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis PD-1 Antibody Drug Product and Services
Table 64. Novartis PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 68. Thermo Fisher Major Business
Table 69. Thermo Fisher PD-1 Antibody Drug Product and Services
Table 70. Thermo Fisher PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Thermo Fisher Recent Developments/Updates
Table 72. Thermo Fisher Competitive Strengths & Weaknesses
Table 73. InvivoGen Basic Information, Manufacturing Base and Competitors
Table 74. InvivoGen Major Business
Table 75. InvivoGen PD-1 Antibody Drug Product and Services
Table 76. InvivoGen PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. InvivoGen Recent Developments/Updates
Table 78. InvivoGen Competitive Strengths & Weaknesses
Table 79. BioVision Inc. Basic Information, Manufacturing Base and Competitors
Table 80. BioVision Inc. Major Business
Table 81. BioVision Inc. PD-1 Antibody Drug Product and Services
Table 82. BioVision Inc. PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. BioVision Inc. Recent Developments/Updates
Table 84. BioVision Inc. Competitive Strengths & Weaknesses
Table 85. Abcam Basic Information, Manufacturing Base and Competitors
Table 86. Abcam Major Business
Table 87. Abcam PD-1 Antibody Drug Product and Services
Table 88. Abcam PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Abcam Recent Developments/Updates
Table 90. Abcam Competitive Strengths & Weaknesses
Table 91. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 92. Bristol-Myers Squibb Major Business
Table 93. Bristol-Myers Squibb PD-1 Antibody Drug Product and Services
Table 94. Bristol-Myers Squibb PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bristol-Myers Squibb Recent Developments/Updates
Table 96. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 97. Merck Basic Information, Manufacturing Base and Competitors
Table 98. Merck Major Business
Table 99. Merck PD-1 Antibody Drug Product and Services
Table 100. Merck PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Merck Recent Developments/Updates
Table 102. Merck Competitive Strengths & Weaknesses
Table 103. Ono Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Ono Pharmaceutical Co., Ltd Major Business
Table 105. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
Table 106. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Ono Pharmaceutical Co., Ltd Recent Developments/Updates
Table 108. Ono Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 109. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 110. Eli Lilly Major Business
Table 111. Eli Lilly PD-1 Antibody Drug Product and Services
Table 112. Eli Lilly PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Eli Lilly Recent Developments/Updates
Table 114. Eli Lilly Competitive Strengths & Weaknesses
Table 115. Chugai Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Chugai Pharmaceutical Co., Ltd Major Business
Table 117. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
Table 118. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Chugai Pharmaceutical Co., Ltd Recent Developments/Updates
Table 120. Chugai Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 121. BeiGene Basic Information, Manufacturing Base and Competitors
Table 122. BeiGene Major Business
Table 123. BeiGene PD-1 Antibody Drug Product and Services
Table 124. BeiGene PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. BeiGene Recent Developments/Updates
Table 126. BeiGene Competitive Strengths & Weaknesses
Table 127. AbbVie Basic Information, Manufacturing Base and Competitors
Table 128. AbbVie Major Business
Table 129. AbbVie PD-1 Antibody Drug Product and Services
Table 130. AbbVie PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. AbbVie Recent Developments/Updates
Table 132. AbbVie Competitive Strengths & Weaknesses
Table 133. TG Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 134. TG Therapeutics, Inc Major Business
Table 135. TG Therapeutics, Inc PD-1 Antibody Drug Product and Services
Table 136. TG Therapeutics, Inc PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. TG Therapeutics, Inc Recent Developments/Updates
Table 138. TG Therapeutics, Inc Competitive Strengths & Weaknesses
Table 139. Beijing Yiqiao Shenzhou Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 140. Beijing Yiqiao Shenzhou Technology Co., Ltd. Major Business
Table 141. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product and Services
Table 142. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Beijing Yiqiao Shenzhou Technology Co., Ltd. Recent Developments/Updates
Table 144. 3SBio Basic Information, Manufacturing Base and Competitors
Table 145. 3SBio Major Business
Table 146. 3SBio PD-1 Antibody Drug Product and Services
Table 147. 3SBio PD-1 Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of PD-1 Antibody Drug Upstream (Raw Materials)
Table 149. PD-1 Antibody Drug Typical Customers
Table 150. PD-1 Antibody Drug Typical Distributors
List of Figure
Figure 1. PD-1 Antibody Drug Picture
Figure 2. World PD-1 Antibody Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World PD-1 Antibody Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World PD-1 Antibody Drug Production (2018-2029) & (K Units)
Figure 5. World PD-1 Antibody Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World PD-1 Antibody Drug Production Value Market Share by Region (2018-2029)
Figure 7. World PD-1 Antibody Drug Production Market Share by Region (2018-2029)
Figure 8. North America PD-1 Antibody Drug Production (2018-2029) & (K Units)
Figure 9. Europe PD-1 Antibody Drug Production (2018-2029) & (K Units)
Figure 10. China PD-1 Antibody Drug Production (2018-2029) & (K Units)
Figure 11. Japan PD-1 Antibody Drug Production (2018-2029) & (K Units)
Figure 12. PD-1 Antibody Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World PD-1 Antibody Drug Consumption (2018-2029) & (K Units)
Figure 15. World PD-1 Antibody Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States PD-1 Antibody Drug Consumption (2018-2029) & (K Units)
Figure 17. China PD-1 Antibody Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe PD-1 Antibody Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan PD-1 Antibody Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea PD-1 Antibody Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN PD-1 Antibody Drug Consumption (2018-2029) & (K Units)
Figure 22. India PD-1 Antibody Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of PD-1 Antibody Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for PD-1 Antibody Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for PD-1 Antibody Drug Markets in 2022
Figure 26. United States VS China: PD-1 Antibody Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: PD-1 Antibody Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: PD-1 Antibody Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers PD-1 Antibody Drug Production Market Share 2022
Figure 30. China Based Manufacturers PD-1 Antibody Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers PD-1 Antibody Drug Production Market Share 2022
Figure 32. World PD-1 Antibody Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World PD-1 Antibody Drug Production Value Market Share by Type in 2022
Figure 34. Pembrolizumab
Figure 35. Nivolumab
Figure 36. Sindilimab
Figure 37. Toripalimab
Figure 38. Other
Figure 39. World PD-1 Antibody Drug Production Market Share by Type (2018-2029)
Figure 40. World PD-1 Antibody Drug Production Value Market Share by Type (2018-2029)
Figure 41. World PD-1 Antibody Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 42. World PD-1 Antibody Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 43. World PD-1 Antibody Drug Production Value Market Share by Application in 2022
Figure 44. Hospital
Figure 45. Clinic
Figure 46. Other
Figure 47. World PD-1 Antibody Drug Production Market Share by Application (2018-2029)
Figure 48. World PD-1 Antibody Drug Production Value Market Share by Application (2018-2029)
Figure 49. World PD-1 Antibody Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. PD-1 Antibody Drug Industry Chain
Figure 51. PD-1 Antibody Drug Procurement Model
Figure 52. PD-1 Antibody Drug Sales Model
Figure 53. PD-1 Antibody Drug Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
